Cannabinoid CB2 Receptor Mediates Nicotine-Induced Anti-Inflammation in N9 Microglial Cells Exposed to β Amyloid via Protein Kinase C
Background. Reducing β amyloid- (Aβ-) induced microglial activation is considered to be effective in treating Alzheimer's disease (AD). Nicotine attenuates Aβ-induced microglial activation; the mechanism, however, is still elusive. Microglia could be activated into classic activated state (M1 s...
Saved in:
Main Authors: | Ji Jia (Author), Jie Peng (Author), Zhaoju Li (Author), Youping Wu (Author), Qunlin Wu (Author), Weifeng Tu (Author), Mingchun Wu (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
On the role of cannabinoid CB1- and µ-opioid receptors in nicotine-induced motor impulsivity
by: Joost eWiskerke, et al.
Published: (2012) -
Cannabinoid CB2 Receptors Contribute to Upregulation of β-endorphin in Inflamed Skin Tissues by Electroacupuncture
by: Su Tang-feng, et al.
Published: (2011) -
Cannabinoid CB2 Receptors Modulate Microglia Function and Amyloid Dynamics in a Mouse Model of Alzheimer's Disease
by: Samuel Ruiz de Martín Esteban, et al.
Published: (2022) -
Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1-CB2 Heteroreceptor Complexes
by: Gemma Navarro, et al.
Published: (2018) -
Voltage dependence of the cannabinoid CB1 receptor
by: Esty Goldberger, et al.
Published: (2022)